Estimated pulse wave velocity as a forefront indicator of developing metabolic syndrome in Korean adults
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The predictive value of the estimated pulse wave velocity (ePWV) for the development of metabolic syndrome has not yet been extensively explored. This study aimed to fill this gap by evaluating ePWV as a potential predictor of metabolic syndrome development in middle-aged Korean adults. Methods: Using prospective data obtained from the Ansan-Ansung cohort database, participants without metabolic syndrome at baseline were studied. ePWV was calculated using specific equations based on age and blood pressure. The primary outcome was the incidence of metabolic syndrome during a median follow-up period of 187 months. Results: Among the 6,186 participants, 2,726 (44.1%) developed metabolic syndrome during the follow-up period. ePWV methvalues were categorized into tertiles to assess their predictive value for the development of metabolic syndrome. An ePWV cut-off of 7.407 m/s was identified as a predictor of metabolic syndrome development, with a sensitivity of 0.743 and a specificity of 0.464. Participants exceeding this cut-off, especially those in the third tertile (8.77–14.63 m/s), had a notably higher risk of developing metabolic syndrome. Specifically, the third tertile exhibited a 52.8% cumulative incidence compared with 30.8% in the first tertile. After adjustments, those in the third tertile faced a 1.530-fold increased risk of metabolic syndrome (95% confidence interval, 1.330–1.761). Conclusions: ePWV is a significant predictor of the development of metabolic syndrome. This finding underscores the potential of ePWV as a cardiometabolic risk assessment tool and can thus provide useful information for primary prevention strategies.
Abstract
Background/Aims: The predictive value of the estimated pulse wave velocity (ePWV) for the development of metabolic syndrome has not yet been extensively explored. This study aimed to fill this gap by evaluating ePWV as a potential predictor of metabolic syndrome development in middle-aged Korean adults. Methods: Using prospective data obtained from the Ansan-Ansung cohort database, participants without metabolic syndrome at baseline were studied. ePWV was calculated using specific equations based on age and blood pressure. The primary outcome was the incidence of metabolic syndrome during a median follow-up period of 187 months. Results: Among the 6,186 participants, 2,726 (44.1%) developed metabolic syndrome during the follow-up period. ePWV methvalues were categorized into tertiles to assess their predictive value for the development of metabolic syndrome. An ePWV cut-off of 7.407 m/s was identified as a predictor of metabolic syndrome development, with a sensitivity of 0.743 and a specificity of 0.464. Participants exceeding this cut-off, especially those in the third tertile (8.77–14.63 m/s), had a notably higher risk of developing metabolic syndrome. Specifically, the third tertile exhibited a 52.8% cumulative incidence compared with 30.8% in the first tertile. After adjustments, those in the third tertile faced a 1.530-fold increased risk of metabolic syndrome (95% confidence interval, 1.330–1.761). Conclusions: ePWV is a significant predictor of the development of metabolic syndrome. This finding underscores the potential of ePWV as a cardiometabolic risk assessment tool and can thus provide useful information for primary prevention strategies.
참고문헌 (41)
- Chae J, "Trends and risk factors of metabolic syndrome among Korean adolescents, 2007 to 2018", Diabetes Metab J, 45, pp.880~889 (2021)
- Fahed G, "Metabolic syndrome : updates on pathophysiology and management in 2021", Int J Mol Sci, 23, pp.786~ (2022)
- Nilsson PM, "The metabolic syndrome-what is it and how should it be managed?", Eur J Prev Cardiol, 26(2_suppl), pp.33~46 (2019)
- Grundy SM, "Diagnosis and management of the metabolic syndrome : an American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement, 2005, pp.112, 2735~2752
- Saklayen MG, "The global epidemic of the metabolic syndrome", Curr Hypertens Rep, 20, pp.12~ (2018)
- O’Neill S, "Metabolic syndrome : a closer look at the growing epidemic and its associated pathologies", Obes Rev, 16, pp.1~12 (2015)
- Anderson TJ, "Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk", Can J Cardiol, 22(Suppl B(Suppl B)), pp.72B~80B (2006)
- Cons NC, "Dental care under medicaid; the implementation of title XIX in the state of New York", J Public Health Dent, 27, pp.123~125 (1967)
- Sequí-Domínguez I, "Accuracy of pulse wave velocity predicting cardiovascular and all-cause mortality. a systematic review and meta-analysis", J Clin Med, 9, pp.2080~ (2020)
- Kim HL, "Pulse wave velocity in atherosclerosis", Front Cardiovasc Med, 6, pp.41~ (2019)
- Park JB, "Arteriosclerosis and atherosclerosis assessment in clinical practice : methods and significance", Pulse(Basel), 11, pp.1~8 (2023)
- Greve SV, "Estimated carotid-femoral pulse wave velocity has similar predictive value as measured carotid-femoral pulse wave velocity", J Hypertens, 34, pp.1279~1289 (2016)
- Vianna CA, "Association of pulse wave velocity with body fat measures at 30 y of age", Nutrition, 61, pp.38~42 (2019)
- Yang H, "Pulse wave velocity is decreased with obesity in an elderly Chinese population", J Clin Hypertens(Greenwich), 21, pp.1379~1385 (2019)
- Cohen JB, "Arterial stiffness and diabetes risk in Framingham Heart Study and UK Biobank", Circ Res, 131, pp.545~554 (2022)
- Zheng M, "Arterial stiffness preceding diabetes : a longitudinal study", Circ Res, 127, pp.1491~1498 (2020)
- Agbaje AO, "Effect of arterial stiffness and carotid intima-media thickness progression on the risk of dysglycemia, insulin resistance, and dyslipidemia : a temporal causal longitudinal study", Hypertension, 79, pp.667~678 (2022)
- Kim Y, "Cohort profile : the Korean genome and epidemiology study(KoGES)consortium", Int J Epidemiol, 46, pp.e20~ (2017)
- Kim BY, "2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea", J Obes Metab Syndr, 30, pp.81~92 (2021)
- Reference Values for Arterial Stiffness’ Collaboration, "Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors : ‘establishing normal and reference values’", Eur Heart J, 31, pp.2338~2350 (2010)
- Xu X, "Prevalence of metabolic syndrome among the adult population in western China and the association with socioeconomic and individual factors : four cross-sectional studies", BMJ Open, 12, pp.e052457~ (2022)
- Moore JX, "Metabolic syndrome prevalence by race", ethnicity and sex in the United States, national health and nutrition examination survey, 1988-2012, 2017, pp.14, E24~
- Ranasinghe P, "Prevalence and trends of metabolic syndrome among adults in the asia-pacific region : a systematic review", BMC Public Health, 17, pp.101~ (2017)
- Huh JH, "Metabolic syndrome fact sheet 2021 : executive report", Cardiometab Syndr J, 1, pp.125~134 (2021)
- Kim HJ, "Harnessing metabolic indices as a predictive tool for cardiovascular disease in a Korean population without known major cardiovascular event", Diabetes Metab J (2024)[DOI]
- Park JB, "Expert consensus on the clinical use of pulse wave velocity in Asia", Pulse(Basel), 10, pp.1~18 (2022)
- Kim BS, "Association of the estimated pulse wave velocity with cardio-vascular disease outcomes among men and women aged 40-69 years in the Korean population : an 18-year follow-up report on the Ansung-Ansan cohort in the Korean genome environment study", J Pers Med, 12, pp.1611~ (2022)
- Li D, "Predictive value of estimated pulse wave velocity for cardiovascular and all-cause mortality in individuals with obesity", Diabetol Metab Syndr, 15, pp.40~ (2023)
- Greve SV, "Elevated estimated arterial age is associated with metabolic syndrome and low-grade inflammation", J Hypertens, 34, pp.2410~2417 (2016)
- Vlachopoulos C, "Association of estimated pulse wave velocity with survival : a secondary analysis of SPRINT", JAMA Netw Open, 2, pp.e1912831~ (2019)
- Huang H, "Estimated pulse wave velocity is associated with all-cause and cardio-cerebrovascular disease mortality in stroke population : Results from NHANES(2003-2014)", Front Cardiovasc Med, 10, pp.1140160~ (2023)
- Mancia G, "2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension : endorsed by the International Society of Hypertension(ISH)and the European Renal Association(ERA)", J Hypertens, 41, pp.1874~2071 (2023)
- Guzik TJ, "Oxidative stress, inflammation, and vascular aging in hypertension", Hypertension, 70, pp.660~667 (2017)
- van Bussel BC, "Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period", Hypertension, 58, pp.588~595 (2011)
- Dumor K, "Arterial stiffness in hypertension : an update", Curr Hypertens Rep, 20, pp.72~ (2018)
- Rani V, "Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies", Life Sci, 148, pp.183~193 (2016)
- Hotamisligil GS, "Inflammation and metabolic disorders", Nature, 444, pp.860~867 (2006)
- Starzak M, "Arterial stiffness assessment by pulse wave velocity in patients with metabolic syndrome and its components : is it a useful tool in clinical practice?", Int J Environ Res Public Health, 19, pp.10368~ (2022)
- Lee GP, "Incremental value of the measures of arterial stiffness in cardiovascular risk assessment", Rev Cardiovasc Med, 23, pp.6~ (2022)
- Sabio JM, "Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus", J Rheumatol, 36, pp.2204~2211 (2009)
- Topouchian J, "Effects of metabolic syndrome on arterial function in different age groups : the Advanced Approach to Arterial Stiffness study", J Hypertens, 36, pp.824~833 (2018)